Literature DB >> 11253941

Preparation and characterization of hCG-loaded polylactide or poly(lactide-co-glycolide) microspheres using a modified water-in-oil-in-water (w/o/w) emulsion solvent evaporation technique.

K J Zhu1, H L Jiang, X Y Du, J Wang, W X Xu, S F Liu.   

Abstract

A modified w/o/w emulsion solvent evaporation technique was adopted to prepare human Chorionic Gonadotropin (hCG)-loaded polylactide (PLA) or poly(lactide-co-glycolide) (PLGA) microspheres. The effects of preparative parameters, such as stirring rate, polymer MW and concentration, and the composition of both the inner aqueous phase and oil phase etc., on hCG entrapment efficiency and microsphere characteristics were investigated. It was found that by adding 20% glycerol into the inner aqueous phase and 40% acetone into the oil phase, smooth microspheres approximately 1 microm in diameter could be produced with high hCG entrapment efficiency (>90%). In vitro release test showed a burst release of hCG from PLGA (75:25) microspheres, followed by sustained release of 55% hCG over 2 months. The initial hCG burst from PLGA microspheres increased with the glycerol concentration in the inner aqueous phase, but decreased to a low value (ca. 20%) with the addition of acetone into the oil phase, which could be attributed to the associated changes in surface morphology of the microspheres. In vivo experiments demonstrated that a single shot of hCG-loaded PLGA microspheres could produce a comparable antibody response with the inoculation of free hCG four times.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11253941     DOI: 10.1080/02652040010000474

Source DB:  PubMed          Journal:  J Microencapsul        ISSN: 0265-2048            Impact factor:   3.142


  8 in total

Review 1.  Long-term delivery of protein therapeutics.

Authors:  Ravi Vaishya; Varun Khurana; Sulabh Patel; Ashim K Mitra
Journal:  Expert Opin Drug Deliv       Date:  2014-09-24       Impact factor: 6.648

2.  Control of drug loading efficiency and drug release behavior in preparation of hydrophilic-drug-containing monodisperse PLGA microspheres.

Authors:  Fuminori Ito; Hiroyuki Fujimori; Hiroyuki Honnami; Hiroyoshi Kawakami; Kiyoshi Kanamura; Kimiko Makino
Journal:  J Mater Sci Mater Med       Date:  2010-02-03       Impact factor: 3.896

3.  Repurposing rosiglitazone, a PPAR-γ agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH.

Authors:  Jahidur Rashid; Ahmad Alobaida; Taslim A Al-Hilal; Samia Hammouda; Ivan F McMurtry; Eva Nozik-Grayck; Kurt R Stenmark; Fakhrul Ahsan
Journal:  J Control Release       Date:  2018-04-30       Impact factor: 9.776

4.  The comparison of different daidzein-PLGA nanoparticles in increasing its oral bioavailability.

Authors:  Yiran Ma; Xinyi Zhao; Jian Li; Qi Shen
Journal:  Int J Nanomedicine       Date:  2012-02-02

5.  PLGA-PEG Nanoparticles Coated with Anti-CD45RO and Loaded with HDAC Plus Protease Inhibitors Activate Latent HIV and Inhibit Viral Spread.

Authors:  Xiaolong Tang; Yong Liang; Xinkuang Liu; Shuping Zhou; Liang Liu; Fujina Zhang; Chunmei Xie; Shuyu Cai; Jia Wei; Yongqiang Zhu; Wei Hou
Journal:  Nanoscale Res Lett       Date:  2015-10-22       Impact factor: 4.703

6.  Preparation of uniform-sized GeXIVA[1,2]-loaded PLGA microspheres as long-effective release system with high encapsulation efficiency.

Authors:  Lu Li; Zhiguo Li; Yongxin Guo; Kai Zhang; Weidong Mi; Jing Liu
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

7.  Development of multiple-layer polymeric particles for targeted and controlled drug delivery.

Authors:  Bhanuprasanth Koppolu; Maham Rahimi; Sivaniarvindpriya Nattama; Aniket Wadajkar; Kytai Truong Nguyen
Journal:  Nanomedicine       Date:  2009-08-20       Impact factor: 5.307

8.  Design and Development of Levodopa Loaded Polymeric Nanoparticles for Intranasal Delivery.

Authors:  Mohd Zulhelmy Ahmad; Akmal Hidyat Bin Sabri; Qonita Kurnia Anjani; Juan Domínguez-Robles; Normala Abdul Latip; Khuriah Abdul Hamid
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.